Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

GE Plans To Spin Off Its Healthcare Business

By Mike Botta | June 26, 2018

GE announced Tuesday that it intends to spin off its healthcare business, just days after the company was bounced from the Dow Jones Industrial average, a spot it had held continuously for more than 110 years.

The company also plans to sell its interest in Baker Hughes, a that provides drilling services for the oil and gas industry.

Following a strategic review of its business, GE said it plans to focus on aviation, power, and renewable energy, “creating a simpler, stronger, leading high-tech industrial company.” 

The company plans to separate GE Healthcare into a standalone business, pursue an orderly separation from Baker Hughes over the next two to three years, make its corporate structure leaner, and substantially reduce debt. 

GE Chairman and CEO John Flannery told investors that separating the units will allow them to pursue their own growth strategies. The GE board unanimously approved the plans. 

GE Healthcare recorded more than $19 billion in revenues in 2017 and posted 5 percent revenue growth and 9 percent segment profit growth in the same year. It recorded $19 billion operating profit.

The business provides medical imaging (including contrast agents), monitoring, biomanufacturing, and cell therapy technology, leveraging digital, artificial intelligence, and data analytics capabilities. Its products and services are available in 140 countries around the world. 

GE said it expects to generate cash from the disposition of approximately 20 percent of its interest in healthcare and to distribute the remaining 80 percent to GE shareholders through a tax-free distribution. 

The timing of the announced transactions will be determined at a later date, but are expected to be completed over the next 12 to 18 months, according to the company.

GE Healthcare is expected to conduct business as usual throughout the process.

(Sources: GE, Associated Press; AP Photo/John Minchillo) 

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE